FIELD: biotechnology.
SUBSTANCE: antibody that binds to the epidermal HER2/CD340 growth factor receptor is disclosed. Application of this antibody to treat cancer with HER2 overexpression is also considered. The antibody of the present invention binds to domain I of the extracellular portion of HER2.
EFFECT: high efficiency of cancer treatment.
3 cl, 4 dwg, 2 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MUTANT FULLY HUMANISED ANTIBODY AGAINST HER2 AND ENCODING GENE AND THEIR APPLICATION | 2015 |
|
RU2639531C1 |
| POLYSPECIFIC ANTIBODIES | 2009 |
|
RU2547596C2 |
| TARGETED/IMMUNOMODULATING FUSION PROTEINS AND METHODS FOR THEIR OBTAINING | 2013 |
|
RU2636342C2 |
| ALLOSTERIC ANTIBODIES AGAINST HUMAN HER3 NON COMPETITIVE FOR NEUREGULIN AND USE THEREOF | 2013 |
|
RU2704228C2 |
| CHIMERIC ANTIGEN RECEPTORS WITH MUTATED CD28 COSTIMULATION DOMAINS | 2018 |
|
RU2800922C2 |
| USE OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE IN THE TREATMENT OF UROTHELIAL CARCINOMA | 2019 |
|
RU2750817C1 |
| RECOMBINANT Fab-scFv BASED ON A NEUTRALISING ANTIBODY AGAINST HUMAN BETA-1A INTERFERON AND AN ANTIBODY AGAINST HUMAN ErbB2 RECEPTOR | 2019 |
|
RU2748953C1 |
| ANTIBODIES PRIMARILY BINDING TO EXTRACELLULAR DOMAIN 4 OF HUMAN CSF-1R, AND USING THEM | 2010 |
|
RU2565541C2 |
| ANTI-HER2 ANTIBODY AND CONJUGATE THEREOF | 2014 |
|
RU2656161C1 |
| ANTIBODIES-ANTAGONISTS AGAINST Notch3 AND THEIR APPLICATION FOR PREVENTION AND TREATMENT OF Notch3-RELATED DISEASES | 2007 |
|
RU2493167C2 |
